Matches in Wikidata for { <http://www.wikidata.org/entity/Q74277146> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q74277146 description "clinical trial" @default.
- Q74277146 description "ensayu clínicu" @default.
- Q74277146 description "klinisch onderzoek" @default.
- Q74277146 description "клінічне випробування" @default.
- Q74277146 name "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy" @default.
- Q74277146 name "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy" @default.
- Q74277146 type Item @default.
- Q74277146 label "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy" @default.
- Q74277146 label "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy" @default.
- Q74277146 prefLabel "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy" @default.
- Q74277146 prefLabel "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy" @default.
- Q74277146 P1050 Q74277146-8015D81F-B3AD-4BA3-9D6E-F610D6DAC2FA @default.
- Q74277146 P1132 Q74277146-7044A237-E269-420F-88F3-89B23D372359 @default.
- Q74277146 P1476 Q74277146-3E4AD01F-6DEE-4452-959E-EE113138B103 @default.
- Q74277146 P2899 Q74277146-22A48327-D3CD-450A-93D4-3741E7BD568F @default.
- Q74277146 P3098 Q74277146-84377B0D-1D30-41D6-9D16-F6DA06A86CC7 @default.
- Q74277146 P31 Q74277146-A0E770FF-14DE-4C7C-B830-4B305CAE09A7 @default.
- Q74277146 P4135 Q74277146-F751032B-8F12-4E66-A922-D8568572945A @default.
- Q74277146 P580 Q74277146-C825CDA2-6391-4266-A0A7-FA86F426C449 @default.
- Q74277146 P582 Q74277146-59C0D8DB-9F48-4E21-98FF-CEEAE24A9F70 @default.
- Q74277146 P6099 Q74277146-3B774721-787C-448F-889D-D9BA1EE5D805 @default.
- Q74277146 P8363 Q74277146-51459EBD-3ECC-4488-9733-55406D7CA436 @default.
- Q74277146 P1050 Q170990 @default.
- Q74277146 P1132 "+390" @default.
- Q74277146 P1476 "A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Filgotinib in Subjects With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy" @default.
- Q74277146 P2899 "+18" @default.
- Q74277146 P3098 "NCT04115839" @default.
- Q74277146 P31 Q30612 @default.
- Q74277146 P4135 "+75" @default.
- Q74277146 P580 "2019-11-01T00:00:00Z" @default.
- Q74277146 P582 "2021-09-01T00:00:00Z" @default.
- Q74277146 P6099 Q42824827 @default.
- Q74277146 P8363 Q78089383 @default.